Patients who get blood work through Labcorp can now receive AI-generated plain-language explanations of their results inside ...

Traditionally thought of as a disease related to aging and "wear and tear," osteoarthritis (OA) is now recognized as a disease of the whole joint. By far the most common form of arthritis, OA does not ...

Replacing the AHA's Patients' Bill of Rights, the Patient Care Partnership is a plain language brochure that informs patients about what they should expect during their hospital stay with regard to ...

Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered ...

Labcorp Holdings Inc. , a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on Thursday, July ...

LH expands specialty testing, acquisitions and AI initiatives to drive growth, but macro pressures and currency headwinds could weigh on results.

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

First FDA-approved, at-home screening test that uses RNA technology to detect biomarkers associated with colorectal cancer and advanced adenomas Designed to reduce common barriers to at-home screening ...

In August 2021, NHS England published the outcome of a review into non-emergency patient transport services (NEPTS). The review set out a new national framework for NEPTS, with the aim of ensuring ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...